Litcius/Paper detail

Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression

Thomas Stehlé, Philippe Grimbert, Philippe Rémy, Anissa Moktefi, Vincent Audard, Khalil El Karoui

2022Kidney International18 citationsDOI

Topics & Concepts

ImmunosuppressionMedicineMembranous nephropathyNephropathyInternal medicineImmunologyGlomerulonephritisKidneyEndocrinologyDiabetes mellitusRenal Diseases and GlomerulopathiesChronic Lymphocytic Leukemia ResearchComplement system in diseases
Anti-CD38 therapy for PLA2R-positive membranous nephropathy resistant to conventional immunosuppression | Litcius